---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-25-000109"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2025-05-27T23:59:59+00:00"
generated_at: "2026-05-20T09:59:02.048460+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics shareholders approve 4.325M share increase to 2023 Equity Plan, all directors re-elected

## Summary
- Amendment to 2023 Equity Incentive Plan approved: +4.325M shares, 1-year minimum vesting, no liberal share recycling.
- All nine director nominees elected; votes ranged from 93.7% to 99.1% support (excluding broker non-votes).
- Advisory say-on-pay passed with 81.77% of votes cast; board adopted annual frequency for future votes.
- Ratification of Deloitte & Touche as auditor received 99.86% of votes cast.

## SEC filing metadata
- accession: 0001077183-25-000109
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2025-05-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000109/0001077183-25-000109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718325000109/neo-20250522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-25-000109
- JSON: https://secwatch.observer/filing/0001077183-25-000109.json
- Plain text: https://secwatch.observer/filing/0001077183-25-000109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.